Monitoring cancer can often be an intrusive and exhausting process for patients. But with BYU chemistry professor Ryan Kelly’s new research, there is hope for a simpler way: No more biopsies. No more spinal taps. Instead, patients may be able to take a simple blood test to diagnose, monitor and tailor appropriate therapies for various cancers.